Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

PHASE3CompletedINTERVENTIONAL

Enrollment

562

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

July 31, 2006

Conditions

Hypoactive Sexual Desire Disorder

Interventions

DRUG

Testosterone Transdermal System

testosterone patch, 300mcg/day, changed every 3-4 days for up to 52 weeks

DRUG

Placebo

placebo patch,changed every 3-4 days for 24 weeks during double blind phase

Trial Locations (3)

Research Site, Kansas City

Research Site, Prahran

Research Site, Québec